Artisan Therapeutics and Tulex Pharmaceuticals announced results from a phase 2a clinical trial of ART-501, an oral liquid extended-release formulation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE